• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼肠孤病毒对微卫星稳定型结直肠癌免疫检查点抑制的增强作用

Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer.

作者信息

Augustine Titto, John Peter, Friedman Tyler, Jiffry Jeeshan, Guzik Hillary, Mannan Rifat, Gupta Riya, Delano Catherine, Mariadason John M, Zang Xingxing, Maitra Radhashree, Goel Sanjay

机构信息

Department of Medicine, Albert Einstein College of Medicine, Bronx, NY, United States.

Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, NY, United States.

出版信息

Front Oncol. 2022 Oct 25;12:1018767. doi: 10.3389/fonc.2022.1018767. eCollection 2022.

DOI:10.3389/fonc.2022.1018767
PMID:36387154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9642964/
Abstract

The majority of colorectal cancers (CRCs) are microsatellite stable (MSS) and resistant to immunotherapy. The current study explores the possibility of using oncolytic reovirus to sensitize MSS CRC to immune checkpoint inhibition. While reovirus reduced metabolic activity among cells, microarray/computational analysis revealed microsatellite status-oriented activation of immune-response pathways. Reovirus plus anti-PD-1 treatment increased cell death among MSS cells . Reduced tumorigenicity and proliferative index, and increased apoptosis were evident among CT26 [MSS, ], but not in MC38 [microsatellite unstable/MSI, ] syngeneic mouse models under combinatorial treatment. PD-L1-PD-1 signaling axis were differentially altered among CT26/MC38 models. Combinatorial treatment activated the innate immune system, pattern recognition receptors, and antigen presentation markers. Furthermore, we observed the reduction of immunosuppressive macrophages and expansion of effector T cell subsets, as well as reduction in T cell exhaustion. The current investigation sheds light on the immunological mechanisms of the reovirus-anti-PD-1 combination to reduce the growth of MSS CRC.

摘要

大多数结直肠癌(CRC)是微卫星稳定(MSS)的,并且对免疫疗法耐药。当前研究探索了使用溶瘤呼肠孤病毒使MSS CRC对免疫检查点抑制敏感的可能性。虽然呼肠孤病毒降低了细胞间的代谢活性,但微阵列/计算分析显示了免疫反应途径的微卫星状态导向激活。呼肠孤病毒联合抗PD-1治疗增加了MSS细胞的细胞死亡。在联合治疗下,CT26 [MSS, ]同基因小鼠模型中肿瘤形成能力和增殖指数降低,细胞凋亡增加,但在MC38 [微卫星不稳定/MSI, ]同基因小鼠模型中未观察到这些现象。CT26/MC38模型中PD-L1-PD-1信号轴发生了不同改变。联合治疗激活了先天免疫系统、模式识别受体和抗原呈递标志物。此外,我们观察到免疫抑制性巨噬细胞减少,效应T细胞亚群扩增,以及T细胞耗竭减少。当前研究揭示了呼肠孤病毒-抗PD-1联合治疗减少MSS CRC生长的免疫机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/7b26905fb5df/fonc-12-1018767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/995bcc8399da/fonc-12-1018767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/9578ecfc6b99/fonc-12-1018767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/d26a965a6f7f/fonc-12-1018767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/0f8d3e57b259/fonc-12-1018767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/59f8c6df5c90/fonc-12-1018767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/6870d8f245b9/fonc-12-1018767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/7b26905fb5df/fonc-12-1018767-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/995bcc8399da/fonc-12-1018767-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/9578ecfc6b99/fonc-12-1018767-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/d26a965a6f7f/fonc-12-1018767-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/0f8d3e57b259/fonc-12-1018767-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/59f8c6df5c90/fonc-12-1018767-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/6870d8f245b9/fonc-12-1018767-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e27/9642964/7b26905fb5df/fonc-12-1018767-g007.jpg

相似文献

1
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancer.呼肠孤病毒对微卫星稳定型结直肠癌免疫检查点抑制的增强作用
Front Oncol. 2022 Oct 25;12:1018767. doi: 10.3389/fonc.2022.1018767. eCollection 2022.
2
Presence of Tim3 and PD-1 CD8 T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and distinct clinicopathological features.Tim3 和 PD-1 共表达的 CD8 T 细胞可鉴定出具有免疫衰竭和独特临床病理特征的微卫星稳定型结直肠癌。
J Pathol. 2022 Jun;257(2):186-197. doi: 10.1002/path.5877. Epub 2022 Apr 9.
3
Clinical significance of programmed cell death-ligand 1 expression and the immune microenvironment at the invasive front of colorectal cancers with high microsatellite instability.高微卫星不稳定性结直肠癌侵袭前沿中程序性细胞死亡配体 1 表达和免疫微环境的临床意义。
Int J Cancer. 2018 Feb 15;142(4):822-832. doi: 10.1002/ijc.31107. Epub 2017 Oct 31.
4
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.阻断白介素-17A 可增强微卫星稳定型结直肠癌对 PD-1 免疫治疗的反应。
J Immunother Cancer. 2021 Jan;9(1). doi: 10.1136/jitc-2020-001895.
5
Cytolytic activity correlates with the mutational burden and deregulated expression of immune checkpoints in colorectal cancer.溶细胞活性与结直肠癌中的突变负担和免疫检查点失调表达相关。
J Exp Clin Cancer Res. 2019 Aug 20;38(1):364. doi: 10.1186/s13046-019-1372-z.
6
The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.免疫疗法在结直肠癌中的潜在价值:程序性死亡-1抑制剂治疗的证据综述
Clin Colorectal Cancer. 2016 Dec;15(4):285-291. doi: 10.1016/j.clcc.2016.07.007. Epub 2016 Jul 22.
7
Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.超越微卫星检测:肿瘤突变负荷评估可识别可能对免疫检查点抑制有反应的结直肠癌亚组。
J Gastrointest Oncol. 2018 Aug;9(4):610-617. doi: 10.21037/jgo.2018.05.06.
8
A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ.一部分微卫星稳定/微卫星低度不稳定的结直肠癌患者表现出CD8(+)肿瘤浸润淋巴细胞增加以及干扰素-γ上调。
Oncol Lett. 2019 Dec;18(6):5977-5985. doi: 10.3892/ol.2019.10953. Epub 2019 Oct 2.
9
Targeting MSS colorectal cancer with immunotherapy: are we turning the corner?免疫疗法靶向 MSS 结直肠癌:我们是否即将迎来转机?
Expert Opin Biol Ther. 2021 Oct;21(10):1347-1357. doi: 10.1080/14712598.2021.1933940. Epub 2021 May 31.
10
Fruquintinib Enhances the Antitumor Immune Responses of Anti-Programmed Death Receptor-1 in Colorectal Cancer.呋喹替尼增强抗程序性死亡受体-1在结直肠癌中的抗肿瘤免疫反应。
Front Oncol. 2022 Mar 17;12:841977. doi: 10.3389/fonc.2022.841977. eCollection 2022.

引用本文的文献

1
Oncolytic Viruses as a Novel Therapeutic Approach for Colorectal Cancer: Mechanisms, Current Advances, and Future Directions.溶瘤病毒作为一种治疗结直肠癌的新型方法:作用机制、当前进展及未来方向
Cancers (Basel). 2025 May 31;17(11):1854. doi: 10.3390/cancers17111854.
2
Oncolytic immunovirotherapy: finding the tumor antigen needle in the antiviral haystack.溶瘤免疫病毒疗法:在抗病毒的干草堆中寻找肿瘤抗原这根针。
Immunotherapy. 2025 Jun;17(8):585-594. doi: 10.1080/1750743X.2025.2513853. Epub 2025 Jun 6.
3
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.

本文引用的文献

1
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer.仑伐替尼联合帕博利珠单抗治疗晚期子宫内膜癌。
N Engl J Med. 2022 Feb 3;386(5):437-448. doi: 10.1056/NEJMoa2108330. Epub 2022 Jan 19.
2
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.Relatlimab 和 Nivolumab 对比 Nivolumab 用于未经治疗的晚期黑色素瘤。
N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970.
3
Targeting the NLRP3 Inflammasome as a New Therapeutic Option for Overcoming Cancer.靶向NLRP3炎性小体作为克服癌症的新治疗选择。
中和抗体削弱了呼肠孤病毒的溶瘤效力,但允许与基于 T 细胞的免疫疗法有效联合。
Cancer Immunol Res. 2024 Mar 4;12(3):334-349. doi: 10.1158/2326-6066.CIR-23-0480.
4
Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality.呼肠孤病毒感染肿瘤细胞会降低 NKG2D 配体的表达,从而导致 NK 细胞的细胞毒性和功能受损。
Front Immunol. 2023 Sep 11;14:1231782. doi: 10.3389/fimmu.2023.1231782. eCollection 2023.
5
Rosmarinic acid in combination with ginsenoside Rg1 suppresses colon cancer metastasis via co-inhition of COX-2 and PD1/PD-L1 signaling axis.迷迭香酸与人参皂苷Rg1联合通过共同抑制COX-2和PD1/PD-L1信号轴抑制结肠癌转移。
Acta Pharmacol Sin. 2024 Jan;45(1):193-208. doi: 10.1038/s41401-023-01158-8. Epub 2023 Sep 25.
Cancers (Basel). 2021 May 11;13(10):2297. doi: 10.3390/cancers13102297.
4
Microsatellite Instability as a Predictor of Outcomes in Colorectal Cancer in the Era of Immune-Checkpoint Inhibitors.微卫星不稳定性作为免疫检查点抑制剂时代结直肠癌患者预后的预测因子。
Curr Drug Targets. 2021;22(9):968-976. doi: 10.2174/1389450122666210325121322.
5
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma.仑伐替尼联合帕博利珠单抗或依维莫司治疗晚期肾细胞癌。
N Engl J Med. 2021 Apr 8;384(14):1289-1300. doi: 10.1056/NEJMoa2035716. Epub 2021 Feb 13.
6
Immune checkpoint inhibitors: Significant advancements in non-small cell lung cancer treatment.免疫检查点抑制剂:非小细胞肺癌治疗的重大进展。
Am J Health Syst Pharm. 2021 Apr 22;78(9):769-780. doi: 10.1093/ajhp/zxab041.
7
Molecular Tools for Metastatic Colorectal Cancer Characterization.用于转移性结直肠癌特征分析的分子工具
J Cell Immunol. 2020;2(6):359-363. doi: 10.33696/immunology.2.067.
8
Oncolytic Viruses and Immune Checkpoint Inhibitors: Preclinical Developments to Clinical Trials.溶瘤病毒与免疫检查点抑制剂:从临床前研发到临床试验
Int J Mol Sci. 2020 Nov 16;21(22):8627. doi: 10.3390/ijms21228627.
9
Past, Present and Future of Oncolytic Reovirus.溶瘤呼肠孤病毒的过去、现在与未来
Cancers (Basel). 2020 Oct 31;12(11):3219. doi: 10.3390/cancers12113219.
10
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy.用溶瘤呼肠孤病毒对肿瘤微环境进行预处理可将 CD3 双特异性抗体治疗转化为有效的免疫疗法。
J Immunother Cancer. 2020 Oct;8(2). doi: 10.1136/jitc-2020-001191.